Align Technology, Inc. ("we," "us," "our," "Align" or the "Company") is a global medical device company primarily engaged in the design, manufacture and marketing of Invisalign clear aligners for the treatment of malocclusions, or the misalignment of teeth, by orthodontists and general dental practitioners ("GPs"), ViveraTM retainers for retention, iTeroTM intraoral scanners and services for dentistry, and exocadTM computer-aided design and computer-aided manufacturing ("CAD/CAM") software for dental laboratories and dental practitioners. Our vision and strategy is to revolutionize orthodontic and restorative dentistry through digital treatment planning and implementation using the AlignTM Digital Platform, an integrated suite of proprietary technologies and services designed to deliver a seamless, end-to-end solution for patients, consumers, orthodontists, GPs and lab partners.
Logo and founding year from Wikidata.
As recorded by the SEC for this filer.
As recorded by the SEC for this filer.
No peers found.
No related securities.
No peers found.
No related securities.
| Dec FY2014 | 761.7M |
|---|---|
| Dec FY2015 | 845.5M |
| Dec FY2016 | 1.1B |
| Dec FY2017 | 1.5B |
| Dec FY2018 | 2B |
| Dec FY2019 | 2.4B |
| Dec FY2020 | 2.5B |
| Dec FY2021 | 4B |
| Dec FY2022 | 3.7B |
| Dec FY2023 | 3.9B |
| Dec FY2024 | 4B |
| Dec FY2025 | 4B |
| Sep Q3 FY23 | 960.2M |
|---|---|
| Dec Q4 FY23 | 956.7M |
| Mar Q1 FY24 | 997.4M |
| Jun Q2 FY24 | 1B |
| Sep Q3 FY24 | 977.9M |
| Dec Q4 FY24 | 995.2M |
| Mar Q1 FY25 | 979.3M |
| Jun Q2 FY25 | 1B |
| Sep Q3 FY25 | 995.7M |
| Dec Q4 FY25 | 1B |
| Mar Q1 FY26 | 1B |
| Jun Q2 FY26 | 1.1B |